Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122899 · ClinicalTrials.gov registry record · NA
Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants
A NA study of Sacroiliac Dysfunction, sponsored by SI-BONE.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 11
- Study locations
NCT03122899: Completed NA study of Sacroiliac Dysfunction, sponsored by SI-BONE.
NCT03122899 is a NA study of Sacroiliac Dysfunction that has completed, run by SI-BONE. The registered enrollment target is 51 participants. The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03122899, a NA study of Sacroiliac Dysfunction, has completed, sponsored by SI-BONE.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 11
- Study locations
Study Summary
SALLY studies sacroiliac joint fusion with the iFuse-3D implant.
Conditions Studied
Interventions
- DEVICE SIJ fusion with iFuse-3D
Study Locations (11)
Colorado
- University of Colorado Hospital - Aurora
- Clin Tech Center for Spine Health - Johnstown
California
- Memorial Orthopaedic Surgical Group - Long Beach
Florida
- The B.A.C.K. Center - Melbourne
Illinois
- Orthopedic Center of Southern Illinois - Mount Vernon
Kentucky
- Bluegrass Orthopaedics - Lexington
Louisiana
- LSU Health Sciences Center, Department of Neurosurgery - New Orleans
Missouri
- Columbia Orthopaedic Group - Columbia
Oregon
- South Oregon Orthopedics - Medford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-10-03 |
| Est. Completion | 2024-06-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03122899
The ClinicalTrials.gov registry entry for NCT03122899 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SI-BONE, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sacroiliac Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which SIJ fusion with iFuse-3D is the first listed.
NCT03122899 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Colorado, California, Florida.
Frequently Asked Questions
What is clinical trial NCT03122899 about?
NCT03122899 is a clinical study titled "Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants". SALLY studies sacroiliac joint fusion with the iFuse-3D implant.
What is the current status of trial NCT03122899?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2017-10-03. Estimated completion is 2024-06-19.
What conditions does trial NCT03122899 study?
This clinical trial studies the following conditions: Sacroiliac Dysfunction.
What interventions are being tested in trial NCT03122899?
The interventions under investigation include: SIJ fusion with iFuse-3D (DEVICE).
Who is sponsoring clinical trial NCT03122899?
This trial is sponsored by SI-BONE, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03122899 being conducted?
This trial has 11 study locations across California, Colorado, Florida, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.